Insider · CIK 0002042077
Jorey Chernett
Files at STIM (Neuronetics, Inc.), STLN (Oncology Institute, Inc.), AIRS (Airsculpt Technologies, Inc.). First filing Mar 4, 2026, latest Jun 24, 2026.
Jorey Chernett files SEC Form 4 as 10% owner at AIRS (Airsculpt Technologies, Inc.), and also at STLN (Oncology Institute, Inc.), STIM (Neuronetics, Inc.). Since Mar 4, 2026, Jorey Chernett has reported 31 open-market buys worth $9.1M and 0 open-market sells worth $0, the latest filed on Jun 24, 2026.
A track record needs three past buys with six months of prices behind them; Jorey Chernett has 0, so none is measured yet.
The newest scored trade: bought $90k of STLN on Jun 23, 2026, filed Jun 24, 2026, scored 16 (weak). In the last 12 months: 31 buys worth $9.1M and 0 sells worth $0.
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
AIRS: Airsculpt Technologies, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
STLN: Oncology Institute, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
STIM: Neuronetics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | STLNbuy Oncology Institute, Inc. | $90k 18,000 shares | +0% | +145% from low-5% from high | |
| 14Weak | STLNbuy Oncology Institute, Inc. | $57k 12,000 shares | +0% | +131% from low-1% from high | |
| 18Weak | STLNbuy Oncology Institute, Inc. | $157k 38,500 shares | +0% | +100% from low-14% from high | |
| 17Weak | STLNbuy Oncology Institute, Inc. | $123k 30,000 shares | +0% | +100% from low-14% from high | |
| 35Weak | STIMbuy Neuronetics, Inc. | $117k 100,000 shares | +1% | 0% from low-75% from high | |
| 50Moderate | STIMbuy Neuronetics, Inc. | $637k 475,000 shares | +5% | +4% from low-73% from high | |
| 34Weak | STIMbuy Neuronetics, Inc. | $309k 200,000 shares | +2% | +30% from low-66% from high | |
| 25Weak | AIRSbuy Airsculpt Technologies, Inc. | $102k 40,000 shares | +1% | +62% from low-78% from high | |
| 22Weak | AIRSbuy Airsculpt Technologies, Inc. | $52k 20,000 shares | +0% | +66% from low-78% from high | |
| 22Weak | STLNbuy Oncology Institute, Inc. | $62k 20,000 shares | +0% | +98% from low-35% from high | |
| 27Weak | AIRSbuy Airsculpt Technologies, Inc. | $176k 60,000 shares | +1% | +86% from low-75% from high | |
| 33Weak | AIRSbuy Airsculpt Technologies, Inc. | $254k 90,000 shares | +1% | +101% from low-73% from high | |
| 53Moderate | STIMbuy Neuronetics, Inc. | $675k 500,000 shares | +6% | +6% from low-72% from high | |
| 24Weak | STLNbuy Oncology Institute, Inc. | $81k 27,429 shares | +0% | +167% from low-38% from high | |
| 48Moderate | STIMbuy Neuronetics, Inc. | $482k 385,442 shares | +4% | +4% from low-73% from high | |
| 32Weak | STIMbuy Neuronetics, Inc. | $211k 150,000 shares | +2% | +15% from low-70% from high | |
| 26Weak | STLNbuy Oncology Institute, Inc. | $158k 50,000 shares | +0% | +179% from low-35% from high | |
| 26Weak | AIRSbuy Airsculpt Technologies, Inc. | $146k 50,000 shares | +1% | +76% from low-76% from high | |
| 36Weak | STLNbuy Oncology Institute, Inc. | $389k 125,000 shares | +1% | +182% from low-34% from high | |
| 25Weak | AIRSbuy Airsculpt Technologies, Inc. | $111k 40,000 shares | +1% | +68% from low-77% from high | |
| 24Weak | STLNbuy Oncology Institute, Inc. | $84k 25,000 shares | +0% | +246% from low-30% from high | |
| 33Weak | STIMbuy Neuronetics, Inc. | $239k 169,472 shares | +2% | +19% from low-71% from high | |
| 32Weak | AIRSbuy Airsculpt Technologies, Inc. | $205k 77,702 shares | +1% | +72% from low-77% from high | |
| 48Moderate | STIMbuy Neuronetics, Inc. | $1.4M 1,057,400 shares | +14% | +11% from low-73% from high | |
| 32Weak | AIRSbuy Airsculpt Technologies, Inc. | $212k 83,000 shares | +1% | +70% from low-77% from high | |
| 48Moderate | STIMbuy Neuronetics, Inc. | $616k 531,000 shares | +8% | +0% from low-76% from high | |
| 40Moderate | STLNbuy Oncology Institute, Inc. | $1.2M 398,985 shares | +4% | +337% from low-40% from high | |
| 33Weak | AIRSbuy Airsculpt Technologies, Inc. | $257k 105,848 shares | +2% | +78% from low-76% from high | |
| 32Weak | AIRSbuy Airsculpt Technologies, Inc. | $189k 88,000 shares | +1% | +43% from low-81% from high | |
| 24Weak | AIRSbuy Airsculpt Technologies, Inc. | $91k 45,600 shares | +1% | +32% from low-82% from high | |
| 37Weak | AIRSbuy Airsculpt Technologies, Inc. | $193k 110,000 shares | +2% | +10% from low-85% from high |
Transactions
Every row this insider has filed, 44 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +18,000 | $5.02 | $90k | 10,615,858 | Jun 24, 2026 |
| Jun 4, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +12,000 | $4.75 | $57k | 10,579,858 | Jun 5, 2026 |
| May 19, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +5,000 | $4.05 | $20k | 10,534,358 | May 21, 2026 |
| May 20, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +33,500 | $4.07 | $136k | 10,567,858 | May 21, 2026 |
| May 19, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +30,000 | $4.09 | $123k | 10,529,358 | May 20, 2026 |
| May 19, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +100,000 | $1.17 | $117k | 10,553,988 | May 20, 2026 |
| May 12, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +475,000 | $1.34 | $637k | 10,453,988 | May 13, 2026 |
| Apr 20, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +100,000 | $1.58 | $158k | 9,878,988 | Apr 22, 2026 |
| Apr 21, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +100,000 | $1.51 | $151k | 9,978,988 | Apr 22, 2026 |
| Apr 17, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +40,000 | $2.54 | $102k | 7,053,761 | Apr 20, 2026 |
| Apr 17, 2026 | AIRS Airsculpt Technologies, Inc. | EExpiration of short derivative Call Option (AIRS 17APR26 $4C)derivative | -2,004 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 17, 2026 | AIRS Airsculpt Technologies, Inc. | EExpiration of short derivative Call Option (AIRS 17APR26 $5C)derivative | -2,000 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 14, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +20,000 | $2.60 | $52k | 7,013,761 | Apr 15, 2026 |
| Apr 9, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +20,000 | $3.10 | $62k | 10,499,358 | Apr 13, 2026 |
| Apr 7, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +60,000 | $2.93 | $176k | 6,993,761 | Apr 8, 2026 |
| Apr 3, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +90,000 | $2.82 | $254k | 6,933,761 | Apr 6, 2026 |
| Mar 30, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +385,442 | $1.25 | $482k | 9,778,988 | Mar 30, 2026 |
| Mar 27, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +500,000 | $1.35 | $675k | 9,393,276 | Mar 30, 2026 |
| Mar 27, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +27,429 | $2.96 | $81k | 10,479,358 | Mar 30, 2026 |
| Mar 26, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +50,000 | $3.15 | $158k | 10,451,929 | Mar 27, 2026 |
| Mar 25, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +125,000 | $1.40 | $175k | 8,868,276 | Mar 27, 2026 |
| Mar 26, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +25,000 | $1.44 | $36k | 8,893,276 | Mar 27, 2026 |
| Mar 24, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +125,000 | $3.11 | $389k | 10,401,929 | Mar 25, 2026 |
| Mar 23, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +50,000 | $2.91 | $146k | 6,843,761 | Mar 25, 2026 |
| Mar 23, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Call Option (AIRS 17APR26 $2C)derivative | +2,255 | $1.30 | $2,932 | 6,547 | Mar 25, 2026 |
| Mar 23, 2026 | AIRS Airsculpt Technologies, Inc. | SOpen-market sale Call Option (AIRS 17APR26 $2C)derivative | -6,547 | $1.13 | $7,398 | 0 | Mar 25, 2026 |
| Mar 23, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Call Option (AIRS 17APR26 $4C)derivative | +2,004 | $0.50 | $1,002 | 2,004 | Mar 25, 2026 |
| Mar 23, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Call Option (AIRS 17APR26 $5C)derivative | +2,000 | $0.33 | $660 | 2,000 | Mar 25, 2026 |
| Mar 20, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +40,000 | $2.77 | $111k | 6,793,761 | Mar 23, 2026 |
| Mar 20, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +25,000 | $3.35 | $84k | 10,276,929 | Mar 23, 2026 |
| Mar 20, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +169,472 | $1.41 | $239k | 8,743,276 | Mar 23, 2026 |
| Mar 18, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +607,400 | $1.35 | $820k | 8,123,804 | Mar 20, 2026 |
| Mar 19, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +77,702 | $2.64 | $205k | 6,753,761 | Mar 20, 2026 |
| Mar 19, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +450,000 | $1.33 | $599k | 8,573,804 | Mar 20, 2026 |
| Mar 17, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +83,000 | $2.56 | $212k | 6,676,059 | Mar 18, 2026 |
| Mar 17, 2026 | STIM Neuronetics, Inc. | POpen-market purchase Common Stock | +531,000 | $1.16 | $616k | 7,516,404 | Mar 18, 2026 |
| Mar 13, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +263,000 | $2.92 | $768k | 10,115,944 | Mar 17, 2026 |
| Mar 16, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +60,985 | $3.29 | $201k | 10,176,929 | Mar 17, 2026 |
| Mar 17, 2026 | STLN Oncology Institute, Inc. | POpen-market purchase Common Stock | +75,000 | $3.42 | $257k | 10,251,929 | Mar 17, 2026 |
| Mar 16, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +105,848 | $2.43 | $257k | 6,592,059 | Mar 16, 2026 |
| Mar 11, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +88,000 | $2.15 | $189k | 6,486,211 | Mar 11, 2026 |
| Mar 6, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +45,600 | $2.00 | $91k | 6,398,211 | Mar 9, 2026 |
| Mar 3, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +80,000 | $1.71 | $137k | 6,322,611 | Mar 4, 2026 |
| Mar 4, 2026 | AIRS Airsculpt Technologies, Inc. | POpen-market purchase Common Stock | +30,000 | $1.87 | $56k | 6,352,611 | Mar 4, 2026 |
Questions about Jorey Chernett
Answered from the filings on this page, as of the latest one.
Is Jorey Chernett buying or selling?
In the last 12 months Jorey Chernett reported 31 open-market buys worth $9.1M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $90k of STLN on Jun 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Jorey Chernett's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jorey Chernett has 0.
Where does Jorey Chernett file Form 4?
Jorey Chernett has filed Form 4 at AIRS (Airsculpt Technologies, Inc.); STLN (Oncology Institute, Inc.); STIM (Neuronetics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.